Journal
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Volume 37, Issue 6, Pages 1042-1049Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.b14-00116
Keywords
microglia; nitric oxide (NO); inducible NO synthase; lipopolysaccharide; interferon beta; signal transduction and activator of transcription 1 (STAT1)
Categories
Funding
- Japan Society for the Promotion of Science [23590644]
- Grants-in-Aid for Scientific Research [23590644] Funding Source: KAKEN
Ask authors/readers for more resources
Chalcones are open-chain flavonoids that are biosynthesized in various plants. Some of them possess anti-inflammatory activity. We previously found that chalcone glycosides from Brassica rapa L. 'hidabeni' suppress lipopolysaccharide (LPS)-induced nitric oxide (NO) production in rat microglia highly aggressively proliferating immortalized (HAPI) cells. In this study, to explore chalcone derivatives with potent NO inhibitory activity, we synthesized ten compounds based on 'hidabeni' chalcone and examined their effects on LPS-triggered inducible NO synthase (iNOS) expression and NO production. Compounds C4 and C10 potently inhibited NO production (IC50: 4.19, 2.88 mu M, respectively). C4 and C10 suppressed LPS-induced iNOS expression via the inhibition of the signal transduction and activator of transcription 1 (STAT1), but not nuclear factor-kappa B (NF-kappa B), c-Jun N terminal kinase (JNK), and p38, pathways. C10, but not C4, inhibited activation of the MEK/extracellular signal-regulated kinase (ERK) pathway. C4 and C10 also suppressed LPS-induced expression of interferon regulatory factor 1 (IRF-1), which is an important transcription factor involved in iNOS expression. Our findings indicate that these chalcone derivatives are candidate compounds for preventing microglia-mediated neuroinflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available